Demosthenes Bouros is an expert in Pulmonology at Athens Medical Center (Greece). As of July 2026, ScienceLeadR ranks Demosthenes Bouros in the top 1% of experts worldwide for Lung Diseases, Interstitial. Demosthenes Bouros has authored 377 publications, the most recent in 2026, and is an investigator in 4 clinical trials. SLR score: 1,272 (community average: 125). How the SLR is computed.

LeadR Profile

Demosthenes Bouros Athens Medical Center Greece
1 272 ScienceLeadR Reputation 1272
Network Map

Pulmonology

Subspecialties: Hematology - Immunology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1988 - 2026

Source: PubMed

National and Kapodistrian University of Athens

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Pulmonary Alveolar Proteinosis in Greece-Türkiye-Cyprus: Answers in a Real-Life Comparison.
PMID 42457194 — pulmonary alveolar proteinosis, fibrosis, pulmonary fibrosis, therapeutics
Respirology20261
Effects of Tirzepatide on Body Composition, Metabolic Parameters, and Sleep Outcomes: A Real-World One-Year Prospective Study.
PMID 42147626 — glucagon-like peptide 1, insulin resistance, insulin, sleep, apnea, body composition, transaminases, body weight, obesity, sleep apnea syndromes, therapeutics, waist circumference, prospective studies, glycemic control
Cureus20260
Deep-Learning Algorithm Diagnostic Support for Usual Interstitial Pneumonia Pattern Recognition in Fibrotic Interstitial Lung Disease.
PMID 41923409 — idiopathic pulmonary fibrosis, lung, disease progression, pulmonologists, classification, algorithms, radiology, pneumonia, deep learning, lung diseases, learning, lung diseases, interstitial
Respirology20260
Clinical characteristics of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia.
PMID 41561106 — cells, bronchi, signs and symptoms, neuroendocrine cells, hyperplasia
ERJ Open Res20261
Complete Blood Cell Count Parameters Predict Mortality in Patients with Hypersensitivity Pneumonitis.
PMID 40310410 — cells, mortality, monocytes, area under curve, blood, hypersensitivity, eosinophils, biomarkers, alveolitis, extrinsic allergic, cell count, blood cells, blood cell count
Diagnostics (Basel)20250

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 2 2
N/A 1
Phase 3 1

By status:

Completed 3
Active not recruiting 1

By type:

Interventional 3
Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 3

Main Topics

LeadR Networks

Main global connection map